The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000.

Détails

ID Serval
serval:BIB_28955
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000.
Périodique
Clinical Microbiology and Infection
Auteur⸱e⸱s
Turner P.J., Greenhalgh J.M.
Collaborateur⸱rice⸱s
MYSTIC Study Group (Europe)
ISSN
1198-743X (Print)
ISSN-L
1198-743X
Statut éditorial
Publié
Date de publication
2003
Volume
9
Numéro
6
Pages
563-567
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
In vitro susceptibilities to meropenem and comparators of Acinetobacter strains isolated from serious infections in 37 European hospital centers participating in the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program (1997-2000) were tested. There were 635 Acinetobacter strains collected: 490 A. baumannii; 51 A. calcoaceticus var. lwoffii; and 94 other Acinetobacter strains. Overall, meropenem and imipenem were the most effective agents tested. Resistance to the antimicrobials was: 14%, meropenem; 16%, imipenem; 39%, piperacillin-tazobactam; 41%, tobramycin; 45%, ceftazidime; and 53%, ciprofloxacin. Thus, the carbapenems have useful activity against Acinetobacter spp. and represent a viable choice for treating infections caused by these organisms.
Mots-clé
Acinetobacter/drug effects, Acinetobacter Infections/drug therapy, Acinetobacter baumannii/drug effects, Acinetobacter calcoaceticus/drug effects, Anti-Bacterial Agents/pharmacology, Carbapenems/pharmacology, Drug Resistance, Bacterial/physiology, Europe, Humans, Thienamycins/pharmacology
Pubmed
Web of science
Open Access
Oui
Création de la notice
19/11/2007 13:26
Dernière modification de la notice
20/08/2019 14:08
Données d'usage